Maxigesic approval positive for AFT Pharmaceuticals
Trainee reporter
funded through
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
You can cancel anytime with two clicks, an email or a phone call.
Find out
more.
We are serious about journalism.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Or use the information you’ve already given Google to create your subscription.
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
Volatile stocks drive NZ sharemarket down nearly 0.5%
The S&P/NZX 50 Index closed at 12.844.59, declining 60.45 points or 0.47%.
Manufacturing emissions fell 6.2% in September quarter
Manufacturing GDP was down 2.6% in the same quarter.
Lyttelton Port result improves but CEO says it's not enough
The CEO says Lyttelton Port does not generate sufficient returns on its capital base.
Shining bright: Why gold matters today
The “great wealth store” remains a smart portfolio choice in 2025.
Why Kiwis are embracing Bitcoin ETFs
The once hard-to-access investment option is becoming mainstream.
